UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 404

Sortiert nach

Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies

Journal of biological regulators and homeostatic agents, 2020-03, Vol.34 (2), p.327-331

2020

Volltextzugriff (PDF)

Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy

Journal of biological regulators and homeostatic agents, 2020-01, Vol.34 (1), p.9-14

2020

Volltextzugriff (PDF)

How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1

Journal of biological regulators and homeostatic agents, 2020-03, Vol.34 (2), p.333-338

2020

Volltextzugriff (PDF)

Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy

Journal of biological regulators and homeostatic agents, 2020-11, Vol.34 (6), p.1971

2020

Volltextzugriff (PDF)

Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL‐37

Cell proliferation, 2018-10, Vol.51 (5), p.e12475-n/a

2018

Volltextzugriff (PDF)

Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19

Journal of biological regulators and homeostatic agents, 2020-09, Vol.34 (5), p.1629-1632

2020

Volltextzugriff (PDF)

Interleukin-1 family cytokines and mast cells: activation and inhibition

Journal of biological regulators and homeostatic agents, 2019-01, Vol.33 (1), p.1-6

2019

Volltextzugriff (PDF)

The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem

Journal of biological regulators and homeostatic agents, 2021-01, Vol.35 (1), p.1-4

2021

Volltextzugriff (PDF)

The management of knee osteoarthritis in elderly: results from a national survey compared to ESCEO guidelines

European review for medical and pharmacological sciences, 2022-11, Vol.26 (1 Suppl), p.24

2022

Volltextzugriff (PDF)

Treating cancer and no-cancer pain in older and oldest old patients

Current pharmaceutical design, 2015-01, Vol.21 (13), p.1706

2015

Volltextzugriff (PDF)

IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra)

Journal of biological regulators and homeostatic agents, 2020-09, Vol.34 (5), p.1623-1627

2020

Volltextzugriff (PDF)

Anaphylaxis is a rare reaction in COVID-19 vaccination

Journal of biological regulators and homeostatic agents, 2021-05, Vol.35 (3), p.839-842

2021

Volltextzugriff (PDF)

New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators

Journal of biological regulators and homeostatic agents, 2018-05, Vol.32 (3), p.449-454

2018

Volltextzugriff (PDF)

Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited?

Journal of biological regulators and homeostatic agents, 2019-05, Vol.33 (3), p.669-673

2019

Volltextzugriff (PDF)

CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37

Journal of biological regulators and homeostatic agents, 2019-11, Vol.33 (6), p.1981-1985

2019

Volltextzugriff (PDF)

Antibodies for COVID-19 - which, when and how long?

Journal of biological regulators and homeostatic agents, 2021-03, Vol.35 (2), p.417-422

2021

Volltextzugriff (PDF)

Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real‐world data from a large Italian database

British journal of dermatology (1951), 2020-07, Vol.183 (1), p.172-174

2020

Volltextzugriff (PDF)

IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells

Immunological investigations, 2017-04, Vol.46 (3), p.239-250

2017

Volltextzugriff (PDF)

An update on rehabilitative treatment of shoulder disease after breast cancer care

Musculoskeletal surgery, 2024-03, Vol.108 (1), p.31-45

2024

Volltextzugriff (PDF)

Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity

Journal of biological regulators and homeostatic agents, 2019-09, Vol.33 (5), p.1321-1326

2019

Volltextzugriff (PDF)

Adverse events in dry needling and mesotherapy treatment for localized myofascial and muscoloskeletal pain

Journal of biological regulators and homeostatic agents, 2020-03, Vol.34 (2), p.705-707

2020

Volltextzugriff (PDF)

Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects

Journal of biological regulators and homeostatic agents, 2018-11, Vol.32 (6), p.1355-1360

2018

Volltextzugriff (PDF)

Low-grade chronic inflammation mediated by mast cells in fibromyalgia

Journal of biological regulators and homeostatic agents, 2018-03, Vol.32 (2), p.195

2018

Volltextzugriff (PDF)

Activation and inhibition of adaptive immune response mediated by mast cells

Journal of biological regulators and homeostatic agents, 2017-07, Vol.31 (3), p.543-548

2017

Volltextzugriff (PDF)

Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues

Journal of biological regulators and homeostatic agents, 2017-04, Vol.31 (2), p.263-267

2017

Volltextzugriff (PDF)

1 – 25 von 404

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies

Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy

How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1

Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy

Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL‐37

Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19

Interleukin-1 family cytokines and mast cells: activation and inhibition

The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem

The management of knee osteoarthritis in elderly: results from a national survey compared to ESCEO guidelines

Treating cancer and no-cancer pain in older and oldest old patients

IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra)

Anaphylaxis is a rare reaction in COVID-19 vaccination

New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators

Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited?

CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37

Antibodies for COVID-19 - which, when and how long?

Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real‐world data from a large Italian database

IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells

An update on rehabilitative treatment of shoulder disease after breast cancer care

Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity

Adverse events in dry needling and mesotherapy treatment for localized myofascial and muscoloskeletal pain

Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects

Low-grade chronic inflammation mediated by mast cells in fibromyalgia

Activation and inhibition of adaptive immune response mediated by mast cells

Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues

Suchergebnisse filtern